1 active not recruiting, 1 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 1, Terminated 1 |
Follow Metastatic Prostate Carcinoma: new trials by email Literature Review of Metastatic Prostate Carcinoma trials Research Report on Metastatic Prostate Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer Computed Tomography, Fluciclovine F18, Positron Emission Tomography - Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 4 | Terminated | M.D. Anderson Cancer Center | 2 | 2019-09-19 | 2025-01-16 |
| Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer GnRH agonist/antagonist, Prednisone, Abiraterone Acetate - Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma | Phase 4 | Active not recruiting | Northwestern University | 100 | 2017-03-31 | 2026-02-24 |
Prostatic Neoplasms (2) · Cognitive Dysfunction (1) · Dementia (1) · Prostatic Neoplasms, Castration-Resistant (1)
Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Prostatic Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cognition Disorders (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1)
Abiraterone Acetate (1) · Gonadotropin-Releasing Hormone (1) · Magnetic Resonance Spectroscopy (1) · Prednisone (1) · enzalutamide (1) · fluciclovine F-18 (1)
M.D. Anderson Cancer Center (1) · Northwestern University (1)
United States (2)
David VanderWeele, M.D., M.P.H. (1) · Gregory C Ravizzini (1)